NDC 49281-545

ActHIB

Haemophilus Influenzae Type B Strain 1482 Capsular Polysaccharide Tetanus Toxoid Conjugate Antigen

ActHIB is a Kit in the Vaccine category. It is labeled and distributed by Sanofi Pasteur Inc.. The primary component is .

• Product ID: 49281-545_078c8cfc-8409-4ea6-b696-12ba38d7359b
• NDC: 49281-545
• Product Type: Vaccine
• Proprietary Name: ActHIB
• Generic Name: Haemophilus Influenzae Type B Strain 1482 Capsular Polysaccharide Tetanus Toxoid Conjugate Antigen
• Dosage Form: Kit
• Marketing Start Date: 1993-03-30
• Marketing Category: BLA / BLA
• Application Number: BLA103935
• Labeler Name: Sanofi Pasteur Inc.
• Active Ingredient Strength: 0
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 49281-545-03

1 KIT in 1 CARTON (49281-545-03) * .5 mL in 1 VIAL, SINGLE-DOSE (49281-547-58) * .6 mL in 1 VIAL, SINGLE-DOSE (49281-546-58)

• Marketing Start Date: 1993-03-30
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 49281-545-03 [49281054503]

ACTHIB KIT

• Marketing Category: BLA
• Application Number: BLA103935
• Product Type: VACCINE
• Billing Unit: EA
• Marketing Start Date: 2016-06-02

NDC 49281-545-05 [49281054505]

ACTHIB KIT

• Marketing Category: BLA
• Application Number: BLA103935
• Product Type: VACCINE
• Billing Unit: EA
• Marketing Start Date: 1993-03-30
• Marketing End Date: 2016-06-02

Drug Details